Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Cancer Biotherapy ; (6): 775-782, 2021.
Artículo en Chino | WPRIM | ID: wpr-887409

RESUMEN

@#[摘 要] 目的:检测lncRNA LOC440173在NSCLC组织和细胞中的表达及探讨其对癌细胞恶性生物学行为的影响。方法:选取河北医科大学第四医院生物标本库中2014至2017年手术切除的72例NSCLC患者的癌及癌旁组织标本,应用qPCR法检测NSCLC组织和癌旁组织中,以及6种NSCLC细胞株(H520、H358、A549、HCC827、H1703和H1299)中LOC440173的表达水平;构建LOC440173的敲低及过表达载体,分别转染H520和H1703细胞,应用MTS、克隆形成及Transwell小室迁移和侵袭实验分别检测敲低及过表达LOC440173对NSCLC细胞增殖、迁移及侵袭能力的影响,qPCR法检测LOC440173对于EMT过程相关标志物(E-cadherin、N-cadherin及vimentin)mRNA表达水平的影响,WB法检测其对E-cadherin、N-cadherin蛋白表达的影响。结果:LOC440173在NSCLC组织中的表达明显高于癌旁组织(P<0.01),并与淋巴结转移、组织学分化程度、TNM分期和肿瘤大小有关联(P<0.05或P<0.01)。敲低LOC440173可以抑制H520细胞的体外增殖、迁移和侵袭(P<0.05或P<0.01),过表达LOC440173可显著促进H1703细胞的增殖、迁移和侵袭(P<0.05或P<0.01)。在转录水平上,敲低LOC440173后,E-cadherin的表达水平升高,间充质相关标志物N-cadherin、vimentin的表达水平降低(P<0.05或P<0.01);而过表达LOC440173后,E-cadherin的表达水平降低,间充质相关标志物N-cadherin、vimentin的表达水平升高(P<0.05或P<0.01)。在转录后水平上,LOC440173负向调节E-cadherin蛋白的表达、正向调节N-cadherin的蛋白表达(均P<0.05)。结论:LOC440173在NSCLC组织中的异常高表达可能与NSCLC的发生发展有关,LOC440173可显著提高NCSCL细胞的体外增殖、迁移、侵袭能力,且其作用机制可能与调控EMT相关基因表达有关。

2.
Basic & Clinical Medicine ; (12): 929-934, 2017.
Artículo en Chino | WPRIM | ID: wpr-612015

RESUMEN

Objective To construct human lung cancer cell model with human MutS homologous protein 2 (hMSH2) overexpression for exploring the effect of hMSH2 molecule in the cytotoxicity of γδ T cell against lung cancer cells.Methods hMSH2 coding sequence was cloned by PCR for construction of recombinant vector which over expressed hMSH2-EGFP fusion protein using homologous recombination.The recombinant vector was transfected to lung cancer cell line NCI-H520 to construct human lung cancer cell model overexpressing hMSH2 molecule.The expression of hMSH2 molecule in NCI-H520 was detected by Western blot.The expression of hMSH2 on the cell membrane was measured by flow cytometry.Cytotoxicity of expanded γδ T cells from peripheral blood mononuclear cells against NCI-H520 cells was detected by LDH release assay in vitro.Results hMSH2 coding sequence (2805 bp) was cloned and the result of restriction endonuclease digestion of Fugw-hMSH2 recombinant vector was accordance with the anticipated objective strip size.Exogenous hMSH2-EGFP fusion protein was expressed in NCIH520 cells.The level of hMSH2 molecule on the surface of NCI-H520 cells with overexpression of hMSH2 was significantly increased (P<0.001).Cytotoxicity of γδ T cells against NCI-H520 cells with overexpression of hMSH2 was significantly increased compared to the wild type NCI-H520 cells (P<0.05).Conclusions Lung cancer cell model that overexpresses hMSH2 molecule is successfully constructed,hMSH2 molecule on the cell membrane is increased and the cytotoxicity of γδ T cells against lung cancer cells is enhanced.

3.
Chongqing Medicine ; (36): 2334-2336, 2017.
Artículo en Chino | WPRIM | ID: wpr-620361

RESUMEN

Objective To investigate the effect of FTY720 and gemcitabine on the proliferation and apoptosis of H520 and A549 cells in non-small cell lung cancer(NSCLC) cell line.Methods The interventional influence on the in vitro cultured NSCLC A549 and H520 cells was performed by selecting 0,2,4,6,8,10 μmol/L concentrations of FTY720,then the absorbance value was detected at 24,48,72 h after culture and the proliferation inhibiting effects of FTY720 on A549 and H520 were observed under the condition of different concentration of FTY720;adding single 7 μmol/L of FTY720,single 0.2 μmol/L gemcitabine and 37 μmol / L FTY720 combined with 0.2 mol/L gemcitabine into A549 and H520 cells lines,then the differences of inhibition and apoptosis after 48 h in the cells of each group were observed.Results The inhibitory effect of different concentrations of FTY270 on NSCLC A549 and H520 cell lines was statistically significant difference (P<0.05).The proliferation inhibiting effect of FTY720 on NSCLC H520 and A549 cell lines had the correlation with the concentration and time.The apoptosis rate of FTY720 combined with gemcitabine on A549 and H520 cells was significantly higher than that of single use in these two drugs (P<0.05).Conclusion FTY720 combined with gemcitabine can significantly inhibit the proliferation of A549 and H520 in human NSCLC,and can effectively promote the apoptosis of cancer cells,and has the higher clinical value.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA